| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T237 |
0-60 |
Sentence |
denotes |
Evidence links COVID-19 to variable degrees of inflammation. |
| T238 |
61-117 |
Sentence |
denotes |
Corticosteroids offer a potent anti-inflammatory option. |
| T239 |
118-230 |
Sentence |
denotes |
However, they do not dictate precise actions and might cause suppression of anti-viral immune responses as well. |
| T240 |
231-316 |
Sentence |
denotes |
Studies show that the use of corticosteroids might accelerate recovery from COVID-19. |
| T241 |
317-436 |
Sentence |
denotes |
There are no controlled clinical trials that show whether the use of corticosteroids can reduce COVID-19-related death. |
| T242 |
437-616 |
Sentence |
denotes |
Moreover, the pro-inflammatory cytokine IL6 is the best-documented cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19. |
| T243 |
617-728 |
Sentence |
denotes |
Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. |
